Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03236831 · ClinicalTrials.gov registry record · NA
AKI Prevention and Early Intervention in Patients Undergoing VAD Placement
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 210
- Enrollment target
NCT03236831: Completed NA study, sponsored by Mayo Clinic.
NCT03236831 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 210 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03236831, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 210 participants
- Enrollment target
Study Summary
The investigators are doing this research to find out if more careful assessment and elimination of potential risk factors of acute kidney injury (AKI) during the subject's perioperative period will reduce their chance of kidney damage and kidney damage related problems.
Interventions
- OTHER Clinical Recommendations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2017-04-11 |
| Est. Completion | 2019-02-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03236831
The ClinicalTrials.gov registry entry for NCT03236831 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clinical Recommendations is the first listed.
NCT03236831 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03236831 about?
NCT03236831 is a clinical study titled "AKI Prevention and Early Intervention in Patients Undergoing VAD Placement". The investigators are doing this research to find out if more careful assessment and elimination of potential risk factors of acute kidney injury (AKI) during the subject's perioperative period will reduce their chance of kidney damage and kidney damage related problems.
What is the current status of trial NCT03236831?
This trial is currently completed. It is a NA study. The enrollment target is 210 participants. The study started on 2017-04-11. Estimated completion is 2019-02-17.
What interventions are being tested in trial NCT03236831?
The interventions under investigation include: Clinical Recommendations (OTHER).
Who is sponsoring clinical trial NCT03236831?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.